Targeted Treatment for Erythrodermic Psoriasis: Rationale and Recent Advances
Article in Drugs (March 2020)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Application of apremilast, a phosphodiesterase 4 inhibitor, in dermatology
Article in Chinese Journal of Dermatology (November 2018)
IL-17–targeting biologics aim to become standard of care in psoriasis
Article in Nature Biotechnology (January 2015)